TrialBMC nephrology2026

APOSCREEN-1 - a prospective, single-arm clinical trial for the implementation of a pharmacy-based screening for cardiovascular-kidney-metabolic risk factors in Schleswig-Holstein.

Eric Amelunxen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.